Korean J Phys Anthropol.  2007 Jun;20(2):83-92.

Tissue Transglutaminase Activates NF-kappaB Pathway in the Atherosclerotic Coronary Artery

Affiliations
  • 1Department of Anatomy, College of Medicine, Kangwon National University, Korea. camackim@kangwon.ac.kr
  • 2Department of Emergency Medicine, College of Medicine, Chungang University, Korea.
  • 3Department of Anatomy, Gachon Medical School, Korea.

Abstract

Molecular mechanism of nuclear factor-kappaB(NF-kappaB) in the atherosclerosis has been unclear. Recently, NF-kappaB activating function of tissue transglutaminase (tTGase), multifunctional calcium-dependent transamidation enzyme, have been reported in the various tissues like neuroglia. In this report, we investigated the immunoreactivity of tTGase at the human atherosclerotic coronary artery, and examined the effect of tTGase on the well-known proatherogenic NF-kappaB pathway using tTGase-overexpressed cells. Immunohistochemical studies on autopsy samples showed that immunoreactivity of tTGase was markedly elevated in the neointimal tissues of atherosclerotic coronary arteries with progression of disease. Immunohistochemical staining also demonstrated that phosphorylated I-kappaB was activated in the atherosclerotic vessel wall. In vitro study using rat cardiomyoblast (H9c2) and tTGase-overexpressed H9c2 showed that activated tTGase enhanced the phosphorylation of I-kappaB, and this activation was inhibited by tTGase specific inhibitors. These findings suggest that cytosolic tTGase may serve as an activator of NF-kappaB.

Keyword

Tissue transglutaminase; NF-kappaB; Atherosclerosis; Coronary artery

MeSH Terms

Animals
Atherosclerosis
Autopsy
Coronary Vessels*
Cytosol
Humans
Neuroglia
NF-kappa B*
Phosphorylation
Rats
NF-kappa B
Full Text Links
  • KJPA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr